TGFB1 and heart disorder: Increasing evidence indicates that targeting TGF-β1/Smad-specific miRNAs related to fibrosis may be a better approach for combating heart disease [38–40], with miR-21 being the best characterized miRNA associated with TGF-β1-mediated fibrosis [41].